Indaptus Therapeutics, Inc. (INDP) stock

INDPNasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 5/30

$3.15−0.06 (-1.87%)

Close on Nov 12, 2026Market cap $419.71MP/E –Yield –

Indaptus Therapeutics statistics

53 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings: Q3 FY2026, expected soon
Last ex-dividend date: No dividends
Fundamentals through: Jun 30, 2026
Share price as of: Nov 12, 2026

Valuation ratiosIndustry

Market Cap: $419.71M; $280.48M
Enterprise Value: $408.16M; $148.62M
PB Ratio: 36.91; 2.05
P/TBV Ratio: 36.91; 2.29

Share statisticsIndustry

Shares Outstanding: 133M; 58M
Shares Change (YoY): 7105.4%; 10.9%
Shares Change (QoQ): 17.7%; 0.51%
Shares Held by Institutions: 0.29%; 56.4%

Short sellingIndustry

Short Interest: 1M; –
Short Interest Change: 33.0%; -0.76%
Short % of Shares Outstanding: 0.86%; 6.30%
Days to Cover: 3.96; 5.13

Stock price statisticsIndustry

52-Week High: $5.96; –
52-Week Low: $0.92; –
20-Day Moving Average: $3.15; –
50-Day Moving Average: $2.92; –
200-Day Moving Average: $2.31; –
Average True Range (14): $0.36; –
Price Change (1 Week): -0.32%; 1.51%
Price Change (1 Month): 42.5%; -2.35%
Price Change (3 Months): 194.4%; -21.1%
Price Change (6 Months): 80.0%; -22.6%
Price Change (YTD): 8.25%; -22.6%
Price Change (1 Year): 15.8%; -20.7%
Price Change (3 Years): -94.9%; -27.4%
Price Change (5 Years): -98.5%; -77.3%
Price Change (10 Years): -100.0%; -62.7%
Average Volume (10 Days): 221,863; –
Average Volume (20 Days): 258,892; –
Average Volume (90 Days): 683,463; –
Relative Volume: 0.17; 0.79
Relative Strength Index (14): 52.3; 44.7
Volatility (1 Year): 205.1%; 80.4%
Beta (5 Years): 1.06; 1.07

Returns on capitalIndustry

Return on Equity (ROE): -318.0%; -51.2%
Return on Assets (ROA): -163.8%; -40.6%

EfficiencyIndustry

Profits Per Employee: -$3.08M; -$683.67K
Employee Count: 5; 75
WACC: 10.3%; 10.1%

Income statement (TTM)Industry

Operating Income: -$14.77M; -$20.99M
Net Income: -$15.42M; -$21.61M
EBITDA: -$14.77M; -$16.85M
EPS (Diluted): -$7.74; -$0.75

Balance sheetIndustry

Cash & Short-Term Investments: $11.55M; $67.63M
Net Cash (Debt): $11.55M; $17.46M
Net Cash Per Share: $0.09; $0.72
Equity (Book Value): $11.37M; $53.27M
Book Value Per Share: $0.09; $1.50
Tangible Book Value: $11.37M; $26.82M

Cash flow (TTM)Industry

Operating Cash Flow: -$14.70M; -$12.27M

Dividends and yieldsIndustry

Earnings Yield: -3.67%; -20.8%

Scores and fair valueIndustry

Altman Z-Score: 395.13; 0.30
Piotroski F-Score: 2; 4

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.

Period	INDP	S&P 500	Difference	INDP per year	S&P 500 per year
1 month	+29.1%	-2.7%	+31.8 pts
3 months	+208.8%	-1.7%	+210.6 pts
Year to date	+8.2%	+11.9%	−3.6 pts
1 year	+9.0%	+12.0%	−3.0 pts
3 years	-95.2%	+78.2%	−173.3 pts	-63.6%	+21.2%
5 years	-98.5%	+73.2%	−171.7 pts	-56.8%	+11.6%
10 years	-100.0%	+309.6%	−409.6 pts	-55.7%	+15.1%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

1M INDP shares were sold short on Oct 30, 2026, up 33.0% from the previous report. At recent volumes it would take 4.0 days to buy them back. Over the last 20 sessions, 64.5% of the volume reported to FINRA was short selling.

Settlement date	Shares short	Change	Avg. daily volume	Days to cover
Oct 30, 2026	1,139,319	+33.0%	287,809	4.0
Oct 15, 2026	856,708	+4.2%	497,322	1.7
Sep 30, 2026	822,250	-10.3%	794,918	1.0
Sep 15, 2026	916,352	+331.5%	2,311,369	1.0
Aug 31, 2026	212,357	+71.6%	1,455,508	1.0
Aug 14, 2026	123,737	+32.8%	136,608	1.0
Jul 31, 2026	93,141	-64.1%	88,009	1.1
Jul 15, 2026	259,720	+88.8%	75,877	3.4
Jun 30, 2026	137,594	-72.1%	239,554	1.0
Jun 15, 2026	493,245	+2767.7%	5,161,875	1.0
May 29, 2026	17,200	-71.4%	132,680	1.0
May 15, 2026	60,118	-14.6%	64,118	1.0

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?